Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
91.69
-0.75 (-0.81%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Solventum Revenue
Solventum had revenue of $2.21B in the quarter ending June 30, 2026, with 2.22% growth. This brings the company's revenue in the last twelve months to $8.31B, down -0.93% year-over-year. In the year 2025, Solventum had annual revenue of $8.33B with 0.86% growth.
Revenue (ttm)
$8.31B
Revenue Growth
-0.93%
P/S Ratio
1.88
Revenue / Employee
$403,712
Employees
20,584
Market Cap
15.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.33B | 71.00M | 0.86% |
| Dec 31, 2024 | 8.25B | 57.00M | 0.70% |
| Dec 31, 2023 | 8.20B | 67.00M | 0.82% |
| Dec 31, 2022 | 8.13B | -41.00M | -0.50% |
| Dec 31, 2021 | 8.17B | 890.00M | 12.22% |
| Dec 31, 2020 | 7.28B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.47B |
| Alcon | 10.86B |
| Avantor | 6.56B |
| ResMed | 5.65B |
| Bausch + Lomb | 5.32B |
| The Cooper Companies | 4.23B |
| Align Technology | 4.14B |
| AptarGroup | 3.93B |
SOLV News
- 2 days ago - Solventum management to meet with BTIG - TheFly
- 4 days ago - Solventum to Participate in the 2026 Wells Fargo Healthcare Conference - PRNewsWire
- 4 weeks ago - Solventum price target raised to $105 from $92 at Piper Sandler - TheFly
- 4 weeks ago - Solventum price target raised to $101 from $94 at Wedbush - TheFly
- 4 weeks ago - Solventum price target raised to $100 from $90 at Stifel - TheFly
- 4 weeks ago - Solventum price target raised to $101 from $95 at UBS - TheFly
- 4 weeks ago - Solventum price target raised to $84 from $81 at BMO Capital - TheFly
- 4 weeks ago - Solventum price target raised to $113 from $100 at Mizuho - TheFly